...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Hepatology: Official Journal of the American Association for the Study of Liver Diseases >MicroRNA-195 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting the expression of VEGF, VAV2, and CDC42
【24h】

MicroRNA-195 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting the expression of VEGF, VAV2, and CDC42

机译：MicroRNA-195通过抑制VEGF，VAV2和CDC42的表达来抑制肝细胞癌的血管生成和转移

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Hepatocellular carcinoma (HCC) is characterized by active angiogenesis and metastasis, which account for rapid recurrence and poor survival. There is frequent down-regulation of miR-195 expression in HCC tissues. In this study, the role of miR-195 in HCC angiogenesis and metastasis was investigated with in vitro capillary tube formation and transwell assays, in vivo orthotopic xenograft mouse models, and human HCC specimens. Reduction of miR-195 in HCC tissues was significantly associated with increased angiogenesis, metastasis, and worse recurrence-free survival. Both gain-of-function and loss-of-function studies of in vitro models revealed that miR-195 not only suppressed the ability of HCC cells to promote the migration and capillary tube formation of endothelial cells but also directly repressed the abilities of HCC cells to migrate and invade extracellular matrix gel. Based on mouse models, we found that the induced expression of miR-195 dramatically reduced microvessel densities in xenograft tumors and repressed both intrahepatic and pulmonary metastasis. Subsequent investigations disclosed that miR-195 directly inhibited the expression of the proangiogenic factor vascular endothelial growth factor (VEGF) and the prometastatic factors VAV2 and CDC42. Knockdown of these target molecules of miR-195 phenocopied the effects of miR-195 restoration, whereas overexpression of these targets antagonized the function of miR-195. Furthermore, we revealed that miR-195 down-regulation resulted in enhanced VEGF levels in the tumor microenvironment, which subsequently activated VEGF receptor 2 signaling in endothelial cells and thereby promoted angiogenesis. Additionally, miR-195 down-regulation led to increases in VAV2 and CDC42 expression, which stimulated VAV2/Rac1/CDC42 signaling and lamellipodia formation and thereby facilitated the metastasis of HCC cells. Conclusion: miR-195 deregulation contributes to angiogenesis and metastasis in HCC. The restoration of miR-195 expression may be a promising strategy for HCC therapy.
机译：肝细胞癌（HCC）的特征在于活跃的血管生成和转移，这说明了其快速复发和不良生存。 HCC组织中miR-195表达频繁下调。在这项研究中，miR-195在HCC血管生成和转移中的作用已通过体外毛细管形成和Transwell测定，体内原位异种移植小鼠模型以及人类HCC标本进行了研究。肝癌组织中miR-195的减少与血管生成，转移和无复发生存率显着增加相关。体外模型的功能获得和功能丧失研究均显示，miR-195不仅抑制HCC细胞促进内皮细胞迁移和毛细管形成的能力，而且直接抑制HCC细胞的能力迁移并侵入细胞外基质凝胶。基于小鼠模型，我们发现诱导表达的miR-195大大降低了异种移植肿瘤中的微血管密度，并抑制了肝内和肺转移。随后的研究表明，miR-195直接抑制促血管生成因子血管内皮生长因子（VEGF）和促转移因子VAV2和CDC42的表达。击倒这些靶标的miR-195分子表象了miR-195还原的作用，而这些靶标的过表达拮抗了miR-195的功能。此外，我们发现miR-195的下调导致肿瘤微环境中的VEGF水平升高，随后激活了内皮细胞中的VEGF受体2信号传导，从而促进了血管生成。此外，miR-195的下调导致VAV2和CDC42表达增加，从而刺激VAV2 / Rac1 / CDC42信号传导和片状脂蛋白形成，从而促进HCC细胞的转移。结论：miR-195失调有助于肝癌的血管生成和转移。 miR-195表达的恢复可能是HCC治疗的一种有前途的策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号